Previous close | 43.00 |
Open | 43.00 |
Bid | 32.60 |
Ask | 33.50 |
Strike | 210.00 |
Expiry date | 2025-01-17 |
Day's range | 43.00 - 43.00 |
Contract range | N/A |
Volume | |
Open interest | 36 |
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
NetApp (NTAP), Agnico Eagle (AEM), ResMed (RMD), Charles River (CRAI) and Leidos Holdings (LDOS) could be compelling picks in the final quarter of the year.
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date